sarscov
singlestrand
plussens
rna
viru
genom
kb
sequenc
close
resembl
previous
character
coronavirus
sarscov
recogn
caus
deadli
sar
human
coronavirus
known
account
cold
sarscov
appear
new
human
support
find
human
sera
collect
sar
outbreak
contain
antibodi
viru
incub
period
day
sar
patient
might
develop
fever
headach
dri
cough
pneumonia
patient
gradual
recov
progress
respiratori
distress
syndrom
mortal
rate
genomewid
chang
human
gene
express
challeng
novel
pathogen
essenti
unknown
profil
gene
express
pattern
help
defin
complex
biolog
process
associ
health
diseas
vivo
investig
host
respons
infect
vitro
model
offer
insight
mechan
pathogenesi
highlight
potenti
applic
microarray
technolog
diagnos
infect
vivo
whitney
et
al
observ
variat
gene
express
pattern
blood
healthi
subject
strikingli
smaller
signific
chang
induc
diseas
either
patient
cancer
bacteri
infect
conceiv
microarray
profil
gene
express
whole
blood
exhibit
potenti
monitor
patient
respons
diseas
especi
novel
infect
sar
mani
discrimin
method
develop
analysi
microarray
gene
express
data
cancer
patient
result
classif
correl
close
clinic
paramet
instanc
discoveri
signatur
gene
breast
cancer
microarray
analysi
gene
express
provid
us
precis
clinic
stage
improv
outcom
treatment
howev
clinic
paramet
alway
discret
pattern
like
continu
fashion
absolut
classif
may
achiev
herein
present
use
cdna
microarray
analysi
gene
express
whole
blood
cohort
recov
sar
patient
diseas
sever
appear
continuum
identifi
molecular
signatur
gene
accur
discrimin
acut
sar
patient
nonsar
control
rank
diseas
sever
patient
use
gener
associ
plot
gap
ellipt
seriat
algorithm
base
express
profil
gene
deriv
sever
rank
patient
prove
close
correl
clinic
paramet
name
recoveri
period
day
clinic
pulmonari
infect
score
use
cdna
microarray
spot
duplic
cdna
clone
analyz
rna
specimen
success
amplifi
peripher
blood
collect
confirm
sar
patient
age
rang
year
old
mean
sd
median
surviv
except
one
patient
die
day
durat
hospit
cohort
rang
day
n
mean
sd
median
addit
file
defin
specimen
acut
sar
use
follow
criteria
whole
blood
rna
hospit
patient
pcr
posit
sarscov
ii
specimen
collect
within
day
diseas
onset
patient
whose
blood
later
diagnos
elisaposit
antisar
igg
rest
rna
specimen
sar
patient
label
recov
sar
rs
studi
includ
normal
control
nc
volunt
patient
bacteri
infect
healthi
nonsar
infect
control
respect
addit
file
compar
gene
express
profil
among
acut
sar
recov
sar
rs
bacteri
infect
normal
control
nc
group
observ
varianc
gene
express
sar
asr
bacteri
group
equal
higher
healthi
control
nc
fig
result
indic
gene
express
profil
either
sar
bacteri
group
differ
significantli
normal
control
probe
set
gene
standard
deviat
greater
across
array
select
analys
averag
linkag
hierarch
cluster
tree
pearson
correl
proxim
built
array
nc
use
gene
fig
nc
group
well
separ
two
opposit
coher
cluster
singular
valu
decomposit
svd
analysi
dimens
reduct
method
project
gene
express
profil
fewer
repres
eigenvector
also
success
separ
nc
specimen
three
cluster
first
two
eigenvector
fig
interestingli
recov
sar
rs
sampl
interspers
among
sampl
identifi
gene
specif
regul
sarscov
perform
two
set
twosampl
student
ttest
mean
unequalvari
assumpt
first
set
contrast
versu
nona
nc
specimen
gene
gene
signific
test
result
consid
specif
induc
sarscov
fig
b
second
set
ttest
compar
nc
nonnc
specimen
consid
chang
signific
gene
identifi
second
ttest
induc
bacteri
viral
infect
fig
gene
identifi
two
set
test
rank
separ
accord
correspond
set
pvalu
gene
express
profil
top
bottom
gene
set
display
figur
unexpectedli
gene
specif
upregu
sarscov
est
gene
annot
previous
fig
hand
sarscov
stimul
host
innat
immun
upregul
gene
includ
defensin
eosinophil
deriv
neurotoxin
similar
bacteri
infect
fig
simpl
knearestneighbour
method
use
obtain
near
optim
number
gene
filter
gene
set
discrimin
specimen
acut
sar
nonsar
nc
addit
file
select
top
upregul
p
top
downregul
gene
p
versu
nona
nc
student
ttest
use
specif
probe
set
assess
statu
sar
infect
eight
gene
also
signific
nc
versu
nonnc
ttest
exclud
result
specif
probe
set
gene
gap
analysi
calcul
pairwis
euclidean
distanc
among
sampl
rs
nc
use
gene
aim
identifi
onedimension
order
could
reflect
sever
structur
diseas
fig
use
gap
ellipt
arrang
specimen
column
observ
transit
gene
express
pattern
gene
row
left
side
nc
cluster
right
side
accumul
fig
hierarch
cluster
tree
guid
selforgan
map
som
cluster
method
also
perform
sort
sar
patient
sampl
use
gene
robinson
criterion
often
employ
assess
perform
differ
seriat
algorithm
tabl
addit
file
show
gap
algorithm
deriv
smoother
transit
pattern
method
robinson
sens
therebi
deriv
sar
sever
rank
accord
express
profil
signatur
gene
whole
patient
demonstr
smooth
transit
express
level
row
gene
nc
rs
fig
valid
purpos
test
stabil
rank
order
deriv
gap
analysi
gene
specimen
gap
procedur
repeatedli
appli
top
gene
among
filter
gene
signific
pvalu
student
ttest
versu
nona
nc
rank
specimen
obtain
signific
gene
highli
correl
significantli
differ
rank
deriv
set
randomli
select
gene
data
shown
scrutin
clinic
cours
patient
donat
rs
specimen
scatter
among
fig
found
evid
underli
sever
diseas
major
patient
exampl
sampl
patient
discharg
hospit
week
still
pcrposit
sarscov
pcrposit
sampl
group
neg
elisa
result
still
repres
acut
sar
infect
collect
day
respect
patient
sever
sar
cours
hospit
day
respect
patient
second
week
diseas
two
unexplain
specimen
patient
may
repres
uniqu
biolog
variabl
account
misclassif
use
molecular
signatur
test
efficaci
use
gene
molecular
signatur
sever
sar
patient
identifi
signific
correl
p
deriv
rank
sar
sever
number
day
onset
diseas
fig
use
rank
sar
sever
examin
recoveri
trend
recov
patient
donat
multipl
specimen
fig
except
one
patient
shown
red
line
fig
similar
trend
exist
line
pugin
et
al
combin
bodi
temperatur
white
blood
cell
count
volum
appear
tracheal
secret
oxygen
chest
xray
tracheal
aspir
cultur
clinic
pulmonari
infect
score
cpi
diagnost
tool
pneumonia
observ
rank
sar
sever
also
significantli
p
correl
cpi
fig
collect
result
demonstr
correl
molecular
sever
rank
clinic
factor
suggest
use
molecular
signatur
genomewid
paramet
gaug
sever
sar
patient
divers
infect
induc
share
core
gene
express
involv
human
innat
immun
system
infect
may
also
trigger
pathogenspecif
immun
respons
host
innat
immun
gene
upregul
acut
sar
bacteria
infect
patient
fig
sar
novel
viral
infect
encount
human
histori
intriguingli
gene
specif
upregu
sar
patient
est
gene
fig
suggest
first
human
encount
sarscov
might
provok
set
human
gene
poorli
annot
due
disus
annot
est
may
lead
discoveri
novel
gene
given
high
cost
microarray
analys
detect
comprehens
gene
express
profil
may
costeffect
clinic
diagnosi
evalu
patient
infecti
diseas
howev
complex
system
human
bodi
gene
interplay
intric
circuitri
inadequ
examin
routin
paramet
biochemistri
blood
cell
count
global
physiochem
statu
patient
time
blood
collect
report
appli
gap
method
deriv
smooth
transit
pattern
among
sampl
base
molecular
signatur
consist
gene
turn
use
monitor
sever
clinic
cours
sar
patient
instead
cluster
sampl
discret
group
method
similar
commonlyus
microarray
classif
gap
focus
global
orient
sampletosampl
relationship
instanc
rs
sampl
seriat
rank
fig
rank
order
prove
correl
well
clinic
paramet
fig
gapderiv
rank
sever
also
provid
us
uniqu
way
express
relev
gene
consid
deciph
mean
chang
gene
obtain
microarray
experi
instanc
identifi
correl
chang
matrix
metalloproteinas
addit
file
stimul
importantli
correl
could
reveal
paramet
alon
number
day
diseas
onset
clinic
score
cpi
data
shown
studi
howev
might
technic
limit
rna
isol
clinic
specimen
well
unavoid
samplecollect
bia
first
rna
isol
sar
specimen
rna
amplif
perform
biosafeti
level
laboratori
instrument
rna
quantit
avail
limit
result
fail
gener
arna
sar
specimen
addit
file
unfortun
specimen
contain
specimen
patient
earli
ie
first
week
stage
secondli
sar
patient
donat
blood
specimen
studi
may
belong
milder
subgroup
total
sar
patient
kaohsiung
medic
center
chang
gung
memori
hospit
accord
paper
describ
complet
cohort
sar
patient
intub
mechan
ventil
requir
patient
howev
two
patient
need
intub
addit
file
aforement
two
potenti
limit
may
account
microarray
result
could
detect
correl
possibl
worsen
clinic
cours
recov
describ
peiri
et
al
conclus
propos
use
molecular
signatur
reflect
sever
sar
order
interpret
trend
express
chang
group
gene
within
particular
function
categori
use
gap
methodolog
prove
instrument
determin
sever
sar
deriv
sever
rank
sar
patient
turn
form
gradual
basi
analysi
interact
pattern
provid
us
use
tool
understand
molecular
pathogenesi
novel
viral
infect
illumin
human
gene
express
profil
term
gene
express
peripher
blood
unpreced
infect
sarscov
also
discov
smooth
transit
pattern
sever
normal
control
acut
sar
patient
base
gene
express
profil
gener
associ
plot
gap
rank
sar
sever
significantli
correl
clinic
paramet
blood
specimen
sar
patient
addit
file
collect
may
juli
kaohsiung
medic
center
chang
gung
memori
hospit
cgmh
kaohsiung
citi
southern
taiwan
two
addit
blood
sampl
collect
appar
healthi
individu
recov
sar
infect
month
later
diagnosi
sar
base
guidelin
world
health
organ
comprehens
data
sar
cohort
previous
publish
studi
approv
institut
review
board
cgmh
total
rna
isol
paxgen
blood
rna
system
qiagen
usa
store
rna
purifi
concentr
solut
rneasi
minelut
kit
qiagen
usa
use
linear
rna
amplif
use
riboamp
rna
amplif
kit
arcturu
california
usa
first
strand
nucleas
mix
ad
rna
sampl
rna
purif
amplif
perform
insid
biosafeti
level
laboratori
locat
linkou
medic
center
cgmh
analyz
qualiti
quantiti
amplifi
rna
bioanalyz
agil
ca
usa
antigen
use
sar
detect
elisa
detergentextract
gamma
irradi
vero
cell
infect
sarscov
ident
prepar
uninfect
vero
cell
use
control
patient
sera
dilut
ad
elisa
plate
goat
antihuman
igg
antibodi
conjug
horseradish
peroxidas
dako
cambridgeshir
uk
ad
enzymat
reaction
ad
substrat
ophenylenediamin
optic
densiti
od
measur
nm
wavelength
cutoff
valu
od
sarscov
igg
elisa
sensit
method
confirm
sar
case
specif
healthi
control
group
realtim
quantit
pcr
analysi
sarscov
perform
corprob
develop
cdc
ga
usa
ht
sequenc
detect
system
appli
biosystem
ca
usa
studi
use
gmrcl
human
set
version
chip
previous
describ
twelv
amplifi
rna
sampl
healthi
donor
addit
file
pool
common
refer
everi
array
studi
total
arna
sampl
includ
acut
sar
recov
sar
rs
nonsar
infect
normal
control
nc
analyz
cdna
microarray
test
pool
arna
common
refer
among
arna
prepar
analyz
dyeswap
microarray
design
averag
log
ratio
duplic
spot
slide
dye
swap
experi
averag
log
ratio
deriv
two
slide
use
ng
arna
label
hybrid
use
array
detect
kit
genispher
pa
usa
scan
slide
confoc
scanner
chipread
virtek
canada
acquir
spot
background
intens
genepix
pro
softwar
axon
instrument
inc
ca
usa
carri
withinslid
normal
use
program
written
matlab
softwar
mathwork
inc
usa
assur
reproduc
microarray
system
got
similar
gene
express
profil
replic
sampl
use
hierarch
cluster
analysi
also
got
highli
correl
result
two
specimen
collect
patient
time
interv
one
day
consist
obtain
ident
result
pair
dyeswap
experi
complet
microarray
data
avail
addit
file
perform
hierarch
cluster
use
cluster
treeview
softwar
follow
paramet
standard
deviat
filter
cutoff
point
gene
mark
chang
select
among
array
ii
meancent
gene
normal
gene
iii
cluster
analysi
carri
uncent
correl
array
also
perform
singular
valu
decomposit
svd
analysi
correl
matrix
sampl
first
two
eigenvector
weight
correspond
singular
valu
eigenvalu
sampl
plot
robinson
criterion
frequent
use
assess
perform
sort
algorithm
symmetr
proxim
matric
robinson
matrix
r
rij
symmetr
matrix
rij
rik
j
k
rij
rik
j
k
gap
ellipt
seriat
util
ellips
structur
singular
valu
decomposit
converg
correl
coeffici
matrix
usual
identifi
permut
matrix
near
robinson
form
brief
review
gap
detail
applic
avail
lee
ys
chen
ch
wang
th
design
studi
prepar
manuscript
lee
ys
tienyj
chen
ch
carri
statist
analysi
lee
ys
wang
th
chen
es
wei
ml
chen
lk
carri
microarray
experi
chao
yang
kd
lin
mc
wang
yh
liu
jw
eng
hw
chiang
pc
wu
ts
tsao
kc
huang
cg
wang
hs
lee
ys
obtain
clinic
materi
analyz
clinic
inform
author
read
approv
final
manuscript
